Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Buttgereit

Showing results (141-150 of 148) with videos related to

Pageof 15
Sort By:
You have reached the last page of results.This site can display upto 148 results.
Immunologic Research|July 2, 2011
Immunologically restricted patients exhibit a pronounced inflammation and inadequate response to hypoxia in fracture hematomasPaula Hoff, T Gaber, K Schmidt-Bleek, et al.
Annals of the Rheumatic Diseases|July 23, 2013
EULAR evidence-based and consensus-based recommendations on the management of medium to high-dose glucocorticoid therapy in rheumatic diseasesN Duru, M C van der Goes, J W G Jacobs, et al.
Annals of the Rheumatic Diseases|August 10, 2010
Monitoring adverse events of low-dose glucocorticoid therapy: EULAR recommendations for clinical trials and daily practiceM C van der Goes, J W G Jacobs, M Boers, et al.
Annals of the Rheumatic Diseases|July 31, 2007
EULAR evidence-based recommendations on the management of systemic glucocorticoid therapy in rheumatic diseasesJ N Hoes, J W G Jacobs, M Boers, et al.
Annals of the Rheumatic Diseases|September 19, 2009
Patient and rheumatologist perspectives on glucocorticoids: an exercise to improve the implementation of the European League Against Rheumatism (EULAR) recommendations on the management of systemic glucocorticoid therapy in rheumatic diseasesM C van der Goes, J W G Jacobs, M Boers, et al.
Zeitschrift Fur Rheumatologie|November 6, 2020
[S2k guidelines (executive summary): management of large-vessel vasculitis]J H Schirmer, P M Aries, K Balzer, et al.
Zeitschrift Fur Rheumatologie|November 6, 2020
[S2k guidelines: management of large-vessel vasculitis]J H Schirmer, P M Aries, K Balzer, et al.
The Journal of Rheumatology|June 14, 2000
Analysis of the effect of COX-2 specific inhibitors and recommendations for their use in clinical practiceP E Lipsky, S B Abramson, F C Breedveld, et al.
Pageof 15

Showing results (141-150 of 148) with videos related to

Sort By:
Pageof 15
You have reached the last page of results.This site can display upto 148 results.
Immunologic Research|July 2, 2011
Immunologically restricted patients exhibit a pronounced inflammation and inadequate response to hypoxia in fracture hematomasPaula Hoff, T Gaber, K Schmidt-Bleek, et al.
Annals of the Rheumatic Diseases|July 23, 2013
EULAR evidence-based and consensus-based recommendations on the management of medium to high-dose glucocorticoid therapy in rheumatic diseasesN Duru, M C van der Goes, J W G Jacobs, et al.
Annals of the Rheumatic Diseases|August 10, 2010
Monitoring adverse events of low-dose glucocorticoid therapy: EULAR recommendations for clinical trials and daily practiceM C van der Goes, J W G Jacobs, M Boers, et al.
Annals of the Rheumatic Diseases|July 31, 2007
EULAR evidence-based recommendations on the management of systemic glucocorticoid therapy in rheumatic diseasesJ N Hoes, J W G Jacobs, M Boers, et al.
Annals of the Rheumatic Diseases|September 19, 2009
Patient and rheumatologist perspectives on glucocorticoids: an exercise to improve the implementation of the European League Against Rheumatism (EULAR) recommendations on the management of systemic glucocorticoid therapy in rheumatic diseasesM C van der Goes, J W G Jacobs, M Boers, et al.
Zeitschrift Fur Rheumatologie|November 6, 2020
[S2k guidelines (executive summary): management of large-vessel vasculitis]J H Schirmer, P M Aries, K Balzer, et al.
Zeitschrift Fur Rheumatologie|November 6, 2020
[S2k guidelines: management of large-vessel vasculitis]J H Schirmer, P M Aries, K Balzer, et al.
The Journal of Rheumatology|June 14, 2000
Analysis of the effect of COX-2 specific inhibitors and recommendations for their use in clinical practiceP E Lipsky, S B Abramson, F C Breedveld, et al.
Pageof 15